Edition:
United States

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

5.80USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.80
Open
$5.80
Day's High
$5.90
Day's Low
$5.75
Volume
20,561
Avg. Vol
24,111
52-wk High
$6.10
52-wk Low
$2.30

Latest Key Developments (Source: Significant Developments)

Harvard Bioscience Reports Q4 GAAP Earnings Per Share $0.03
Thursday, 1 Mar 2018 04:01pm EST 

March 1 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE REPORTS FOURTH QUARTER AND YEAR-END 2017 RESULTS.SEES FY 2018 NON-GAAP EARNINGS PER SHARE ABOUT $0.19 TO $0.23.SEES FY 2018 GAAP EARNINGS PER SHARE ABOUT $0.03 TO $0.07.Q4 NON-GAAP EARNINGS PER SHARE $0.05.SEES FY 2018 REVENUE $118 MILLION TO $123 MILLION.Q4 REVENUE ROSE 4 PERCENT TO $27.5 MILLION.Q4 GAAP EARNINGS PER SHARE $0.03.‍HARVARD BIOSCIENCE IS REAFFIRMING ITS FINANCIAL GUIDANCE FOR FULL YEAR 2018​.  Full Article

Harvard Bioscience To Acquire Data Sciences International
Monday, 22 Jan 2018 04:01pm EST 

Jan 22 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC.HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC.HARVARD BIOSCIENCE INC - DEAL FOR APPROXIMATELY $70 MILLION.HARVARD BIOSCIENCE INC - ACQUISITION OF DSI WILL BE ACCRETIVE TO EARNINGS AT CLOSING.HARVARD BIOSCIENCE INC - ‍AS A RESULT OF TRANSACTIONS, MANAGEMENT EXPECTS COMPANY'S FISCAL 2018 ANNUAL REVENUE TO BE BETWEEN $118 MILLION AND $123 MILLION​.HARVARD BIOSCIENCE INC - AS A RESULT OF TRANSACTIONS, MANAGEMENT EXPECTS COMPANY'S FISCAL 2018 ANNUAL REVENUE TO BE BETWEEN $118 MILLION AND $123 MILLION.HARVARD BIOSCIENCE INC - ACQUISITION OF DSI WILL BE FINANCED THROUGH A COMBINATION OF DEBT, PROCEEDS FROM SALE OF DENVILLE, AND CASH ON HAND.HARVARD BIOSCIENCE - EXPECTS TRANSACTION TO GENERATE ABOUT $2.5 MILLION TO $3.5 MILLION IN COMBINED REVENUE & COST SYNERGIES 12 MONTHS FOLLOWING CLOSING.HARVARD BIOSCIENCE - EXPECTS COMBINED REVENUE & COST SYNERGIES FROM DEAL TO INCREASE OVER FIRST 3 YEARS FOLLOWING CLOSING.HARVARD BIOSCIENCE - AS A RESULT OF TRANSACTIONS MANAGEMENT EXPECTS CO'S FISCAL 2018 ANNUAL GAAP EPS TO BE BETWEEN $0.03 - $0.07.HARVARD BIOSCIENCE - AS A RESULT OF TRANSACTIONS MANAGEMENT EXPECTS CO'S FISCAL 2018 ANNUAL NON-GAAP ADJUSTED EPS BETWEEN $0.19 AND $0.23.  Full Article

Harvard Bioscience reports Q3 loss $0.01/shr
Thursday, 26 Oct 2017 04:01pm EDT 

Oct 26 (Reuters) - Harvard Bioscience Inc :Harvard Bioscience reports third quarter 2017 financial results.Sees Q4 2017 non-GAAP earnings per share $0.05 to $0.06.Sees Q4 2017 GAAP loss per share about $0.00 to $0.01.Q3 revenue $25.1 million versus i/b/e/s view $24.6 million.Q3 non-GAAP earnings per share $0.03.Q3 GAAP loss per share $0.01.Q3 earnings per share view $0.03 -- Thomson Reuters I/B/E/S.Harvard Bioscience Inc - ‍reaffirming its Q4 revenue guidance​.  Full Article

Harvard Bioscience Q2 loss per share $0.01
Thursday, 27 Jul 2017 04:02pm EDT 

July 27 (Reuters) - Harvard Bioscience Inc :Harvard Bioscience reports second quarter 2017 financial results.Q2 non-GAAP earnings per share $0.03.Q2 revenue $25.2 million versus i/b/e/s view $24.3 million.Q2 earnings per share view $0.03 -- Thomson Reuters I/B/E/S.Sees FY 2017 non-gaap earnings per share $0.13 to $0.15.Q2 GAAP loss per share $0.01.Sees FY 2017 gaap loss per share about $0.02.Harvard bioscience inc says company expects to report 1% to 2% organic revenue growth in third and fourth quarters of 2017.Harvard Bioscience -now expects 2017 revenues to be flat compared to 2016 revenues on a constant currency basis and excluding AHN disposition.FY2017 earnings per share view $0.15, revenue view $98.7 million -- Thomson Reuters I/B/E/S.  Full Article

Harvard Bioscience reports Q1 non-GAAP earnings $0.02/shr
Thursday, 27 Apr 2017 04:01pm EDT 

April 27 (Reuters) - Harvard Bioscience Inc :Harvard Bioscience reports first quarter 2017 financial results.Q1 non-GAAP earnings per share $0.02.Q1 revenue fell 10.4 percent to $24.2 million.Q1 GAAP loss per share $0.03.Sees FY 2017 non-GAAP earnings per share $0.15 to $0.17.Sees FY 2017 GAAP earnings per share about $0.02 to $0.04.Reaffirming its financial guidance for full year 2017.Non-GAAP earnings per share guidance for FY 17 remains unchanged from that issued on March 9, 2017.  Full Article

Harvard Bioscience Q4 gaap loss per share $0.04
Thursday, 9 Mar 2017 04:01pm EST 

Harvard Bioscience Inc : Harvard Bioscience reports fourth quarter and year-end 2016 results and 2017 financial guidance . Sees FY 2017 non-gaap earnings per share $0.15 to $0.17 . Sees FY 2017 gaap earnings per share about $0.03 to $0.05 . Q4 non-gaap earnings per share $0.04 . Q4 revenue $26.4 million versus I/B/E/S view $27 million . Q4 earnings per share view $0.04 -- Thomson Reuters I/B/E/S . Q4 gaap loss per share $0.04 .Fy2017 earnings per share view $0.19, revenue view $108.1 million -- Thomson Reuters I/B/E/S.  Full Article

Harvard Bioscience Q2 adjusted earnings $0.03/shr
Thursday, 28 Jul 2016 06:15am EDT 

Harvard Bioscience Inc : Harvard Bioscience Reports Second Quarter 2016 Financial Results . Updating Full-Year Financial Guidance To Reflect Current Foreign Currency Exchange Rates, Including Impact Of Brexit Uncertainty . Q2 Shr View $0.03, Rev View $26.6 Mln -- Thomson Reuters I/B/E/S . Sees Full-Year 2016 Non-Gaap Diluted Earnings Per Share Of $0.16 To $0.18 . Fy2016 Shr View $0.18, Rev View $109.7 Mln -- Thomson Reuters I/B/E/S . Q2 Gaap Shr Loss $0.02 . Sees Fy 2016 Gaap Shr About $0.00 To $0.02 . Q2 Revenue Fell 9 Pct To $26.1 Mln .Q2 Non-Gaap Shr $0.03.  Full Article

Harvard Bioscience posts Q1 loss of $0.02/share
Thursday, 12 May 2016 06:00am EDT 

Harvard Bioscience Inc : Harvard Bioscience reports first quarter 2016 financial results . Q1 non-GAAP earnings per share $0.05 . Q1 revenue rose 4.7 percent to $27 million . Q1 GAAP loss per share $0.02 . Reaffirming its financial guidance for full year 2016 .Sees FY 2016 non-GAAP earnings per share $0.17 to $0.19.  Full Article

Harvard Bioscience files for non-timely 10-Q
Tuesday, 10 May 2016 05:53pm EDT 

Harvard Bioscience Inc :Files for non-timely 10-Q - SEC filing.  Full Article